These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33243173)

  • 41. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
    Mazza GL; Petersen MM; Ginos B; Langlais BT; Heon N; Gounder MM; Mahoney MR; Zoroufy AJ; Schwartz GK; Rogak LJ; Thanarajasingam G; Basch E; Dueck AC
    Qual Life Res; 2022 Apr; 31(4):1069-1080. PubMed ID: 34420143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items.
    Taarnhøj GA; Kennedy FR; Absolom KL; Bæksted C; Vogelius IR; Johansen C; Velikova G; Pappot H
    J Pain Symptom Manage; 2018 Sep; 56(3):421-429. PubMed ID: 29807157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.
    Da Silva Lopes AM; Colomer-Lahiguera S; Mederos Alfonso N; Aedo-Lopez V; Spurrier-Bernard G; Tolstrup LK; Pappot H; Aspeslagh S; Rogiers A; Neyns B; Haanen JB; Mitchell SA; Addeo A; Michielin O; Eicher M
    Eur J Cancer; 2021 Nov; 157():225-237. PubMed ID: 34536946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
    Liu L; Suo T; Shen Y; Geng C; Song Z; Liu F; Wang J; Xie Y; Zhang Y; Tang T; Zhang L; Wang W
    Qual Life Res; 2020 Nov; 29(11):3009-3015. PubMed ID: 32564293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study.
    Veldhuijzen E; Walraven I; Belderbos J
    JMIR Cancer; 2021 Sep; 7(3):e26574. PubMed ID: 34519658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
    Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
    J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure.
    Feldman E; Pos FJ; Smeenk RJ; van der Poel H; van Leeuwen P; de Feijter JM; Hulshof M; Budiharto T; Hermens R; de Ligt KM; Walraven I
    ESMO Open; 2023 Feb; 8(1):100775. PubMed ID: 36652781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
    Suzuki Y; Iwamoto T; Uno M; Hatono M; Kajiwara Y; Takahashi Y; Kochi M; Shien T; Kikawa Y; Uemura Y; Hagiwara Y; Yamamoto S; Taira N; Doihara H; Toyooka S
    Breast Cancer; 2023 Sep; 30(5):856-868. PubMed ID: 37422608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE
    Minasian LM; O'Mara A; Mitchell SA
    Patient Relat Outcome Meas; 2022; 13():249-258. PubMed ID: 36524232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04.
    Atkinson TM; Lynch KA; Vera J; Olivares NM; Webb A; Diamond LC; González J; Lubetkin EI; Bucher G; Rosa-Cunha I; Berry-Lawhorn JM; Levine R; Aboulafia D; Schouten J; Holland SM; Cella D; Palefsky JM
    J Patient Rep Outcomes; 2022 Oct; 6(1):108. PubMed ID: 36219358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers.
    Günther M; Hentschel L; Schuler M; Müller T; Schütte K; Ko YD; Schmidt-Wolf I; Jaehde U
    BMC Cancer; 2023 Jul; 23(1):629. PubMed ID: 37407982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT).
    Maddalo M; Buglione M; Pasinetti N; Triggiani L; Costa L; Magrini SM; Murphy BA
    Radiol Med; 2020 Feb; 125(2):228-235. PubMed ID: 31784925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying symptomatic adverse events using the patient-reported outcomes version of the common terminology criteria for adverse events in patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
    Zhu Y; Jean-Baptiste M; Lenderking WR; Bell JA; Revicki DA; Lin HM; Brake R; Reeve BB
    Cancer Med; 2023 Mar; 12(5):5494-5505. PubMed ID: 36583557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
    Reeve BB; McFatrich M; Lin L; Lucas NR; Mack JW; Jacobs SS; Withycombe JS; Baker JN; Freyer DR; Hinds PS
    Cancer; 2021 May; 127(9):1483-1494. PubMed ID: 33332590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients.
    Baeksted C; Pappot H; Nissen A; Hjollund NH; Mitchell SA; Basch E; Bidstrup PE; Dalton SO; Johansen C
    J Patient Rep Outcomes; 2017; 1(1):1. PubMed ID: 29757324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events.
    Gilbert A; Piccinin C; Velikova G; Groenvold M; Kuliś D; Blazeby JM; Bottomley A
    J Clin Oncol; 2022 Nov; 40(32):3770-3780. PubMed ID: 35973158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translation and linguistic validation of the FACT-EGFRI-18 quality of life instrument from English into Dutch.
    Boers-Doets CB; Gelderblom H; Lacouture ME; Bredle JM; Epstein JB; Schrama NA; Gall H; Ouwerkerk J; Brakenhoff JA; Nortier JW; Kaptein AA
    Eur J Oncol Nurs; 2013 Dec; 17(6):802-7. PubMed ID: 23571183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
    Veitch ZW; Shepshelovich D; Gallagher C; Wang L; Abdul Razak AR; Spreafico A; Bedard PL; Siu LL; Minasian L; Hansen AR
    J Natl Cancer Inst; 2021 Aug; 113(8):980-988. PubMed ID: 33616650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.
    Caminiti C; Maglietta G; Arenare L; Di Liello R; Migliaccio G; Barberio D; De Laurentiis M; Di Rella F; Nuzzo F; Pacilio C; Iodice G; Orditura M; Ciardiello F; Di Bella S; Cavanna L; Porta C; Giovanardi F; Ripamonti CI; Bilancia D; Aprile G; Ruelle T; Diodati F; Piccirillo MC; Iannelli E; Pinto C; Perrone F
    Breast; 2024 Oct; 77():103781. PubMed ID: 39059033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.